Tools for Practice Outils pour la pratique


#184 Preventing Allergies with Omega-3 in Pregnancy: Another fishy idea?


CLINICAL QUESTION
QUESTION CLINIQUE
Can fish oil supplementation during pregnancy prevent allergic disease in children?


BOTTOM LINE
RÉSULTAT FINAL
Fish oil in pregnancy is likely ineffective at preventing allergic disease in offspring as decreases in either eczema, food allergies, or asthma in one study are generally not found in others and any positive effects seem to wane over timeEnthusiastic mothers could try fish oil supplements from ~20th week of gestation to delivery to prevent allergic disease in, at best, one in ~20 children 



CFPCLearn Logo

Reading Tools for Practice Article can earn you MainPro+ Credits

La lecture d'articles d'outils de pratique peut vous permettre de gagner des crédits MainPro+

Join Now S’inscrire maintenant

Already a CFPCLearn Member? Log in

Déjà abonné à CMFCApprendre? Ouvrir une session



EVIDENCE
DONNÉES PROBANTES
  • Four Systematic Reviews:1-5 Cochrane best.1   
    • Eight Randomized Controlled Trials (RCTs) with 3,366 pregnant women given ~400-4,500 mg of fish oil daily starting gestational week 20-30Frequently, child’s parents/sibling had allergic disease.  
      • 76 meta-analyses performed: Six statistically significant, with only four of those based on ≥2 studies, at 1-3 years 
        • Any allergy with sensitization (positive skin prick test): Rate Ratio (RR) 0.66 (0.44-0.98)Number Needed to Treat (NNT)=23. 
        • Eczema with sensitization: RR 0.61 (0.39-0.95), NNT=23. 
        • Sensitization to eggs or any allergen: RR 0.55 (0.39-0.77) and 0.70 (0.53-0.94), respectively.   
        • Asthma, rhinitis, peanut allergies, and many others negative.   
        • No increased risk of postpartum hemorrhage. 
    • Most recent systematic review found similar.2  
  • Three studies not included above: 
    • New RCT of 695 children x6 years (mothers took 2.4 g/day fish oil or olive oil from ~24 weeks gestation):6  
      • Persistent wheeze/asthma reduced, Hazard Ratio 0.69 (0.49-0.97), NNT=15.   
      • No effect on other allergic outcome.  
    • Two extended follow-ups of previous studies: 
      • 533 children followed ≤24 years: Some outcomes (example asthma medications use) reduced versus placebo (olive oil) but not versus no supplement.7,8   
      • 706 children x6 years: Allergic disease 31% in both groups.9  
Context:   
  • Fish oil contains the omega-3 or n-3 Long Chain Poly-Unsaturated Fatty Acids eicosapentaenoic acid and docosahexaenoic acid. 
  • Common adverse events include belching (41% versus 10%) and unpleasant taste (26% versus 4%).10   
    • Some studies11,12 found ~10% more drop-outs but not consistent.10 \
  • Fish oil supplementation in pregnancy remains debatable13 but some sites encourage fish/fish oil consumption,14,15 but women should review warnings around possible mercury contamination and excess Vitamin with cod liver oil.15  


Latest Tools for Practice
Derniers outils pour la pratique

#369 Remind me, do medications that target brain amyloid improve my dementia?

Are amyloid-targeting monoclonal antibodies safe and effective for mild cognitive impairment or Alzheimer’s dementia?
Read Lire 0.25 credits available Crédits disponibles

#368 Sodium Restriction in Heart Failure: Beneficial or pouring salt in the wound?

Does sodium restriction improve outcomes in patients with chronic heart failure?
Read Lire 0.25 credits available Crédits disponibles

#367 Oral Calcitonin Gene-related Peptide Antagonists: A painfully long name for the acute treatment of migraines

What are the risks and benefits of ubrogepant for the acute treatment of episodic migraines?
Read Lire 0.25 credits available Crédits disponibles

This content is certified for MainPro+ Credits, log in to access

Ce contenu est certifié pour les crédits MainPro+, Ouvrir une session


Author(s)
Auteur(s)
  • G. Michael Allan MD CCFP
  • Adrienne J Lindblad BSP ACPR PharmD

1. Gunaratne AW, Makrides M, Collins CT. Cochrane Database Syst Rev. 2015; 7:CD010085.

2. Best KP, Gold M, Kennedy D, et al. Am J Clin Nutr. 2016; 103(1):128-43.

3. Klemens C, Berman D, Mozurkewich E. BJOG. 2011; 118:916-25.

4. Kremmyda LS, Vlachava M, Noakes PS, et al. Clin Rev Allergy Immunol. 2011; 41:36-66.

5. Anandan C, Nurmatov U, Sheikh A. Allergy. 2009: 64: 840-8.

6. Bisgaard H, Stokholm J, Chawes BL, et al. N Engl J Med. 2016; 375:2530-9.

7. Hansen S, Strøm M, Maslova E, et al. J Allergy Clin Immunol. 2017; 139:104-11.

8. Olsen SF, Østerdal ML, Salvig JD, et al. Am J Clin Nutr. 2008 Jul; 88(1):167-75.

9. Best KP, Sullivan T, Palmer D, et al. Pediatrics. 2016; 137(6):e20154443.

10. Makrides M, Duley L, Olsen SF. Cochrane Database Syst Rev. 2006; 3:CD003402.

11. Dunstan JA, Mori TA, Barden A, et al. J Allergy Clin Immunol. 2003; 112:1178-84.

12. Furuhjelm C, Warstedt K, Larsson J, et al. Acta Paediatr. 2009; 98:1461-7.

13. Ramaswami R, Serhan CN, Levy BD, et al. N Engl J Med. 2016; 375:2599-601.

14. Nutrition during pregnancy. American Congress of Obstetricians and Gynecologists. Available at: http://www.acog.org/Patients/FAQs/Nutrition-During-Pregnancy#fish. Last accessed: February 10, 2017.

15. Omega-3 fatty acids and fish during pregnancy. Health Canada. Available at: https://www.canada.ca/en/public-health/services/pregnancy/omega-3-fatty-acids-fish-during-pregnancy.html. Last accessed: February 10, 2017.

Authors do not have any conflicts of interest to declare.